FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the field of pharmaceuticals, in particular, to medicinal products applied as a sedative and vasorelaxant agent in functional disorders of the cardiovascular system, neurosis-like conditions associated with high irritability, in sleep-onset insomnia, tachycardia, a state of excitation with pronounced vegetative manifestations, as well as an antispasmodic agent in case of intestinal spasms. The product contains garden balm leaf extract, peppermint oil, motherwort herb extract, and excipients. The components are used in the claimed quantities.
EFFECT: use of the invention reduces the side effects and contraindications by eliminating the bromine-containing compound and reducing the dosage of active ingredients while maintaining the therapeutic effectiveness.
3 cl, 2 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
| COMBINED HYPNOTIC AGENT IN THE FORM OF TABLETS | 2021 |
|
RU2769988C1 |
| LIQUID SEDATIVE | 2021 |
|
RU2779256C1 |
| MEDICINE OF SEDATIVE AND ANTISPASMODIC EFFECT AND METHOD OF PREPARATION (VERSIONS) | 2005 |
|
RU2349334C2 |
| METHOD OF OBTAINING A SOLID FORM OF THE DRUG SEDATIVE AND ANTISPASMODIC ACTION | 2015 |
|
RU2578432C9 |
| SOLID DRUG FORM OF MEDICATION WITH SEDATIVE AND ANTISPASMODIC EFFECT | 2013 |
|
RU2570374C2 |
| COMPOSITION AND METHOD OF PRODUCING MEDICINE | 2017 |
|
RU2675627C1 |
| SEDATIVE AND SPASMOLITHIC MEANS AND METHOD FOR ITS PRODUCTION | 2015 |
|
RU2633064C2 |
| SEDATIVE AND SPASMOLYTIC AGENT | 2014 |
|
RU2535019C1 |
| SEDATIVE DRUG AND METHOD OF MARJORAM ESSENTIAL OIL PREPARING FOR MEDICINAL AIMS | 2000 |
|
RU2157224C1 |
